These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9703937)

  • 1. A semi-empirical Hückel molecular orbital analysis of internucleotide phosphorothioate diesters.
    Weltman JK; Karim AS
    Anticancer Res; 1998; 18(4A):2733-6. PubMed ID: 9703937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ab initio molecular orbital analysis of phosphorothioate mono-anion.
    Weltman JK
    Anticancer Res; 2001; 21(2A):1195-8. PubMed ID: 11396163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phosphorothioate chirality on the grooves of DNA double helices: a molecular dynamics study.
    Mukherjee S; Bhattacharyya D
    Biopolymers; 2004 Feb; 73(2):269-82. PubMed ID: 14755583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorothioate oligonucleotides: chemistry, purification, analysis, scale-up and future directions.
    Zon G; Geiser TG
    Anticancer Drug Des; 1991 Dec; 6(6):539-68. PubMed ID: 1772569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel universal linker for efficient synthesis of phosphorothioate oligonucleotides.
    Wang Z; Olsen P; Ravikumar VT
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(3):259-69. PubMed ID: 17454735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the extent of thiolation and introduction of phosphorothioate internucleotide linkages on the anti-HIV activity of Suligovir [(s4dU)35].
    Horváth A; Beck Z; Bardos TJ; Dunn JA; Aradi J
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5321-3. PubMed ID: 16920358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of oligonucleotides.
    Agrawal S; Zhang R
    Ciba Found Symp; 1997; 209():60-75; discussion 75-8. PubMed ID: 9383569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxide-mediated desulfurization of phosphorothioate oligonucleotides and its prevention.
    Krotz AH; Mehta RC; Hardee GE
    J Pharm Sci; 2005 Feb; 94(2):341-52. PubMed ID: 15614814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reactive derivatives of oligonucleotide phosphorothioate analogs. I. Selective activation of terminal phosphates and preparation of phosphamide derivatives of oligonucleotide phosphorothioate analogs].
    Amirkhanov NV; Zarytova VF
    Bioorg Khim; 1995 May; 21(5):365-75. PubMed ID: 7661862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maleimide-mediated protein conjugates of a nucleoside triphosphate gamma-S and an internucleotide phosphorothioate diester.
    Karim AS; Johansson CS; Weltman JK
    Nucleic Acids Res; 1995 Jun; 23(11):2037-40. PubMed ID: 7596834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards rational design of antisense DNA: molecular modelling of phosphorothioate DNA analogues.
    Jaroszewski JW; Syi JL; Maizel J; Cohen JS
    Anticancer Drug Des; 1992 Jun; 7(3):253-62. PubMed ID: 1610482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vibrational analysis of phosphorothioate DNA: II. The POS group in the model compound dimethyl phosphorothioate [(CH3O)2(POS)]-.
    Steinke CA; Reeves KK; Powell JW; Lee SA; Chen YZ; Wyrzykiewicz T; Griffey RH; Mohan V
    J Biomol Struct Dyn; 1997 Feb; 14(4):509-16. PubMed ID: 9172650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labeling of phosphorothioate antisense oligonucleotides with yttrium-90.
    Watanabe N; Sawai H; Endo K; Shinozuka K; Ozaki H; Tanada S; Murata H; Sasaki Y
    Nucl Med Biol; 1999 Feb; 26(2):239-43. PubMed ID: 10100225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural effect of complete [Rp]-phosphorothioate and phosphorodithioate substitutions in the DNA strand of a model antisense inhibitor-target RNA complex.
    Furrer P; Billeci TM; Donati A; Kojima C; Karwowski B; Sierzchala A; Stec W; James TL
    J Mol Biol; 1999 Jan; 285(4):1609-22. PubMed ID: 9917400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereocontrolled synthesis of oligonucleoside phosphorothioates and PO/PS-chimeric oligonucleotides by using oxazaphospholidine derivatives.
    Oka N; Yamamoto M; Sato T; Wada T
    Nucleic Acids Symp Ser (Oxf); 2008; (52):335-6. PubMed ID: 18776390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of siRNA for therapeutics: efficient synthesis of phosphorothioate RNA utilizing phenylacetyl disulfide (PADS).
    Ravikumar VT; Andrade M; Carty RL; Dan A; Barone S
    Bioorg Med Chem Lett; 2006 May; 16(9):2513-7. PubMed ID: 16481168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of phosphorothioate on charge migration in single and double stranded DNA: a theoretical approach.
    Karwowski BT
    Phys Chem Chem Phys; 2015 Sep; 17(33):21507-16. PubMed ID: 26219639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of diastereomeric ratios of deoxyribonucleoside phosphoramidites on the synthesis of phosphorothioate oligonucleotides.
    Cheruvallath ZS; Sasmor H; Cole DL; Ravikumar VT
    Nucleosides Nucleotides Nucleic Acids; 2000 Mar; 19(3):533-43. PubMed ID: 10843490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide pyrophosphatase/phosphodiesterase 1 is responsible for degradation of antisense phosphorothioate oligonucleotides.
    Wójcik M; Cieślak M; Stec WJ; Goding JW; Koziołkiewicz M
    Oligonucleotides; 2007; 17(1):134-45. PubMed ID: 17461770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of modified cytosine residues in the presence of depurinated DNA.
    Rentel C; Wang X; Batt M; Kurata C; Oliver J; Gaus H; Krotz AH; McArdle JV; Capaldi DC
    J Org Chem; 2005 Sep; 70(20):7841-5. PubMed ID: 16277303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.